This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Fourth quarter revenues from continuing operations of $1.9 billion, up 7.2% versus prior year Adjusted diluted EPS from continuing operations of $1.08, up 4.9% versus prior year Reported diluted...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it will collaborate with the Centers for Disease Control and Prevention (CDC)...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full year 2014 results on Thursday,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the appointment of veteran health plan executive Michael Cole as vice president of...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 33rd Annual J.P. Morgan Healthcare...